X

pharmaceuticals

Indegene crosses $100 million quarterly revenue as Q3 growth accelerates on pharma demand and AI-led services

Indegene Ltd (NSE:INDGN), a life sciences services firm, reported more than 30% year-on-year revenue growth for the December quarter, crossing…

Innova Captab Limited Performance, Market Environment, and Competitive Position

Innova Captab Limited (NSE: INNOVACAP) has emerged as a noteworthy player in India's pharmaceutical landscape, combining contract development and manufacturing…

Innova Captab Limited Accelerating Strategic Growth with Strong Q3 and 9-Month FY26 Performance

Innova Captab Limited (NSE: INNOVACAP/BSE: 544067), is a leading integrated pharmaceutical company with a comprehensive business model spanning the entire…

Innova Captab Limited Reports Robust Q3 FY26 Results. Revenue Surges 42% Amid Global Expansion

Innova Captab Limited (NSE: INNOVACAP | BSE: 544067) announced its unaudited financial results for the third quarter and nine months…

Laurus Labs Q3 FY26 Earnings Results

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active…

J B Chemicals Q3 FY26 Earnings Results

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with…

Syngene Q3 FY26 Earnings Results

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Rossari Biotech Q3 FY26 Earnings Results

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. Their 3…

Why India Still Depends on China for Medicines

India proudly wears the badge of being the “pharmacy of the world.” And on the surface, that claim holds up.…

Unichem Labs Q2 FY26 Earnings Results

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.   Q2 FY26 Earnings Results…